US Stock MarketDetailed Quotes

NRIX Nurix Therapeutics

Watchlist
  • 12.460
  • +0.100+0.81%
Trading Apr 26 15:26 ET
760.90MMarket Cap-4684P/E (TTM)

Nurix Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Feb 29, 2024
(FY)Nov 30, 2023
(Q4)Nov 30, 2023
(Q3)Aug 31, 2023
(Q2)May 31, 2023
(Q1)Feb 28, 2023
(FY)Nov 30, 2022
(Q4)Nov 30, 2022
(Q3)Aug 31, 2022
(Q2)May 31, 2022
Total revenue
30.74%16.59M
99.31%76.99M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
29.84%38.63M
-8.29%6.78M
5.26%10.79M
61.22%11.43M
Operating revenue
30.74%16.59M
99.31%76.99M
123.49%15.16M
71.13%18.47M
168.33%30.68M
31.85%12.69M
29.84%38.63M
-8.29%6.78M
5.26%10.79M
61.22%11.43M
Cost of revenue
Gross profit
Operating expense
11.08%61.8M
4.29%232.05M
9.05%60.49M
1.69%58.48M
0.51%57.44M
6.25%55.64M
50.70%222.49M
22.32%55.47M
46.52%57.51M
70.56%57.15M
Selling and administrative expenses
20.14%11.8M
12.91%42.9M
15.08%10.78M
8.98%10.62M
20.97%11.68M
6.43%9.82M
21.78%38M
6.23%9.37M
16.84%9.75M
28.53%9.65M
-General and administrative expense
20.14%11.8M
12.91%42.9M
15.08%10.78M
8.98%10.62M
20.97%11.68M
6.43%9.82M
21.78%38M
6.23%9.37M
16.84%9.75M
28.53%9.65M
Research and development costs
9.14%50.01M
2.52%189.15M
7.82%49.71M
0.20%47.86M
-3.64%45.76M
6.21%45.82M
58.46%184.5M
26.21%46.11M
54.54%47.76M
82.71%47.49M
Operating profit
-5.28%-45.22M
15.67%-155.06M
6.89%-45.33M
14.35%-40.01M
41.45%-26.77M
-0.49%-42.95M
-55.97%-183.87M
-28.29%-48.69M
-61.11%-46.72M
-73.07%-45.72M
Net non-operating interest income expense
70.84%3.79M
216.94%11.12M
71.21%3.38M
200.30%3.03M
692.36%2.49M
951.66%2.22M
326.12%3.51M
568.81%1.97M
2,487.18%1.01M
83.63%314K
Non-operating interest income
70.84%3.79M
216.94%11.12M
71.21%3.38M
200.30%3.03M
692.36%2.49M
951.66%2.22M
326.12%3.51M
568.81%1.97M
2,487.18%1.01M
83.63%314K
Other net income (expense)
Income before tax
-1.71%-41.43M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-54.07%-180.36M
-24.06%-46.72M
-57.85%-45.71M
-73.00%-45.4M
Income tax
90K
0
Net income
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.4M
Net income continuous Operations
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.4M
Minority interest income
Net income attributable to the parent company
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.93%-41.52M
20.19%-143.95M
10.19%-41.96M
19.09%-36.98M
46.53%-24.28M
4.23%-40.73M
-53.90%-180.36M
-23.91%-46.72M
-58.52%-45.71M
-72.09%-45.4M
Basic earnings per share
-1.33%-0.76
28.57%-2.65
11.49%-0.77
24.44%-0.68
55.45%-0.45
21.05%-0.75
-35.90%-3.71
-2.35%-0.87
-38.46%-0.9
-68.33%-1.01
Diluted earnings per share
-1.33%-0.76
28.57%-2.65
11.49%-0.77
24.44%-0.68
55.45%-0.45
21.05%-0.75
-35.90%-3.71
-2.35%-0.87
-38.46%-0.9
-68.33%-1.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Feb 29, 2024(FY)Nov 30, 2023(Q4)Nov 30, 2023(Q3)Aug 31, 2023(Q2)May 31, 2023(Q1)Feb 28, 2023(FY)Nov 30, 2022(Q4)Nov 30, 2022(Q3)Aug 31, 2022(Q2)May 31, 2022
Total revenue 30.74%16.59M99.31%76.99M123.49%15.16M71.13%18.47M168.33%30.68M31.85%12.69M29.84%38.63M-8.29%6.78M5.26%10.79M61.22%11.43M
Operating revenue 30.74%16.59M99.31%76.99M123.49%15.16M71.13%18.47M168.33%30.68M31.85%12.69M29.84%38.63M-8.29%6.78M5.26%10.79M61.22%11.43M
Cost of revenue
Gross profit
Operating expense 11.08%61.8M4.29%232.05M9.05%60.49M1.69%58.48M0.51%57.44M6.25%55.64M50.70%222.49M22.32%55.47M46.52%57.51M70.56%57.15M
Selling and administrative expenses 20.14%11.8M12.91%42.9M15.08%10.78M8.98%10.62M20.97%11.68M6.43%9.82M21.78%38M6.23%9.37M16.84%9.75M28.53%9.65M
-General and administrative expense 20.14%11.8M12.91%42.9M15.08%10.78M8.98%10.62M20.97%11.68M6.43%9.82M21.78%38M6.23%9.37M16.84%9.75M28.53%9.65M
Research and development costs 9.14%50.01M2.52%189.15M7.82%49.71M0.20%47.86M-3.64%45.76M6.21%45.82M58.46%184.5M26.21%46.11M54.54%47.76M82.71%47.49M
Operating profit -5.28%-45.22M15.67%-155.06M6.89%-45.33M14.35%-40.01M41.45%-26.77M-0.49%-42.95M-55.97%-183.87M-28.29%-48.69M-61.11%-46.72M-73.07%-45.72M
Net non-operating interest income expense 70.84%3.79M216.94%11.12M71.21%3.38M200.30%3.03M692.36%2.49M951.66%2.22M326.12%3.51M568.81%1.97M2,487.18%1.01M83.63%314K
Non-operating interest income 70.84%3.79M216.94%11.12M71.21%3.38M200.30%3.03M692.36%2.49M951.66%2.22M326.12%3.51M568.81%1.97M2,487.18%1.01M83.63%314K
Other net income (expense)
Income before tax -1.71%-41.43M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-54.07%-180.36M-24.06%-46.72M-57.85%-45.71M-73.00%-45.4M
Income tax 90K0
Net income -1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M-58.52%-45.71M-72.09%-45.4M
Net income continuous Operations -1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M-58.52%-45.71M-72.09%-45.4M
Minority interest income
Net income attributable to the parent company -1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M-58.52%-45.71M-72.09%-45.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -1.93%-41.52M20.19%-143.95M10.19%-41.96M19.09%-36.98M46.53%-24.28M4.23%-40.73M-53.90%-180.36M-23.91%-46.72M-58.52%-45.71M-72.09%-45.4M
Basic earnings per share -1.33%-0.7628.57%-2.6511.49%-0.7724.44%-0.6855.45%-0.4521.05%-0.75-35.90%-3.71-2.35%-0.87-38.46%-0.9-68.33%-1.01
Diluted earnings per share -1.33%-0.7628.57%-2.6511.49%-0.7724.44%-0.6855.45%-0.4521.05%-0.75-35.90%-3.71-2.35%-0.87-38.46%-0.9-68.33%-1.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg